Ischemic stroke
Conditions
Interventions
Acute phase group
recovery phase group
sequelae group
prospective observation group:Nil
Sponsors
Zhejiang Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) Those who conform to the diagnostic criteria of Western stroke for ischemic stroke; (2) meet the traditional Chinese medicine stroke in the meridian, the diagnosis of Qi and Yin deficiency caused by blood stasis syndrome; (3) Imaging (CT or MRI) confirmed as a patient with anterior cerebral infarction (OCSP clinical classification is complete anterior circulation infarction or partial anterior circulation infarction); (4) course of disease: 1 to 4 weeks after onset; (5) National Institutes of Health Stroke Scale (NIHSS) scoring criteria, 4 points = NIHSS score = 20 points; (6) first onset or previous history of cerebral infarction but no disability before this episode (modified Rankin scale score = 1; (7) Aged 18-80 years old male and female; (8) Those who volunteered to participate and signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with bleeding tendency or bleeding within 3 months, depression after stroke, dementia, cerebral hemorrhage after cerebral infarction, etc.; patients with post-circulatory infarction (POCI), transient ischemic attack (TIA), Intracranial abnormal vascular network disease, asymptomatic cerebral infarction, unstable vital signs of large area cerebral infarction; (2) Those with other diseases affecting the function of limbs, those with limb dysfunction caused by lameness, osteoarthritis, rheumatoid arthritis, gouty arthritis may affect the neurological function test before treatment; (3) Hemiplegia caused by brain tumor, brain trauma, brain host disease, etc., cerebral embolism caused by rheumatic heart disease, coronary heart disease and other heart disease complicated with atrial fibrillation; (4) Before the disease, due to various diseases and physical weakness, it is impossible to independently complete daily activities and other serious evaluations of efficacy evaluation; (5) Patients with other serious cardiovascular and cerebrovascular diseases, liver, kidney, and hematopoietic system, and those who have recently undergone major surgery and are not suitable for the study; (6) Psychiatric patients, patients with major depression, alcohol dependent or those with a history of drug abuse; (7) Those who are pregnant during pregnancy, lactation, and during the period of taking the medicine or within 3 months after stopping the medication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Types and Distribution of TCM Syndromes;Survival curve analysis; | — |
Countries
China
Contacts
Public ContactHongbo Zhang
Third People's Hospital of Huzhou
Outcome results
None listed